Iram Khan

Person

Issaquah, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Engraftable cell-based immunotherapy for long-term delivery of ther...
- Patent number 11,939,594
- Issue date Mar 26, 2024
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression of FOXP3 in edited CD34+ cells
- Patent number 11,713,459
- Issue date Aug 1, 2023
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked...
- Patent number 11,643,671
- Issue date May 9, 2023
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...
- Publication number 20240287452
- Publication date Aug 29, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...
- Publication number 20240141389
- Publication date May 2, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
- Publication number 20240117352
- Publication date Apr 11, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
WISKOTT-ALDRICH SYNDROME GENE HOMING ENDONUCLEASE VARIANTS, COMPOSI...
- Publication number 20220364123
- Publication date Nov 17, 2022
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- Joel GAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE...
- Publication number 20220064651
- Publication date Mar 3, 2022
- Seattie Children's Hospital d/b/a Seattle Children's Research Institute
- David J. RAWLINGS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC GENOME EDITING IN X-LINKED HYPER IGM SYNDROME
- Publication number 20210324381
- Publication date Oct 21, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS
- Publication number 20210253652
- Publication date Aug 19, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS...
- Publication number 20210230565
- Publication date Jul 29, 2021
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- David J. RAWLINGS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
- Publication number 20210054376
- Publication date Feb 25, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...
- Publication number 20200325494
- Publication date Oct 15, 2020
- Seattle Children's Hospital dba ( Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...
- Publication number 20180282692
- Publication date Oct 4, 2018
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Engraftable cell-based immunotherapy for long-term delivery of ther...

Expression of FOXP3 in edited CD34+ cells

Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked...

Patents Applicationslast 30 patents

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...

THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

WISKOTT-ALDRICH SYNDROME GENE HOMING ENDONUCLEASE VARIANTS, COMPOSI...

TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE...

THERAPEUTIC GENOME EDITING IN X-LINKED HYPER IGM SYNDROME

EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS

BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS...

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...